Brief: Abionyx Pharma Cash Position For Q3 At EUR 1.7 Mln

Abionyx Pharma SA

16/11/2023 17:08

Nov 16 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * REVENUE AND CASH POSITION FOR THE THIRD QUARTER OF 2023
    * AS OF SEPTEMBER 30, 2023, ABIONYX PHARMA'S CASH POSITION
STOOD
AT €1.7 MILLION
    * THE COMPANY RECORDED CONSOLIDATED REVENUE OF €3,595 K FOR
THE
FIRST NINE MONTHS OF THE YEAR, AFTER ELIMINATION OF INTRA-GROUP
TRANSACTIONS
    * CASH POSITION DOES NOT INCLUDE THE €3 MILLION CAPITAL
INCREASE
CARRIED OUT BY ABIONYX PHARMA ON OCTOBER 6, 2023, OR THE
REIMBURSEMENT OF IRIS PHARMA'S FRENCH TAX CREDIT (CIR) IN THE
AMOUNT OF €736 K, ALSO IN OCTOBER 2023


Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansknewsroom@thomsonreuters.com; + 48 58 7785110;))